ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis
Open Access
- 13 June 2017
- journal article
- review article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 15 (1) , 8
Abstract
Adenosine diphosphate (ADP)-ribosylation factor-like tumour suppressor gene 1(ARLTS1) might be associated with an increased risk of several types of familial cancers. However, previous studies have shown that cancer susceptibility is not completely consistent with ARLTS1 polymorphisms, and the precise mechanism remains unknown. Therefore, we conducted a meta-analysis of case-control studies by searching the PubMed, Embase, OVID, Science Direct and Chinese National Knowledge Infrastructure (CNKI) databases. In total, 12 studies met the inclusion criteria and were included in this meta-analysis. Statistical analyses were performed using STATA 11.0 software. Overall, the Cys148Arg T > C variant significantly increased cancer risk (CC vs. TT: OR = 1.27, 95% CI = 1.15–1.41, P < 0.05). The stratification indicated that the Cys148Arg variant is significantly associated with sporadic cancer (CC vs. TT: OR = 1.36, 95% CI = 1.18–1.55) and familial cancer (CC vs. TT: OR = 1.26, 95% CI = 1.12–1.43). Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu were not correlated with cancer susceptibility. Based on these results, we demonstrated that the ARLTS1 Cys148Arg polymorphism is associated with an increased risk of sporadic cancer and familial cancer, and there were no associations between the other four SNPs (i.e., Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu) and cancer risk.Keywords
This publication has 28 references indexed in Scilit:
- The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine–based ER retention motifBlood, 2014
- ARLTS1 and Prostate Cancer Risk - Analysis of Expression and RegulationPLOS ONE, 2013
- The Bleeding Risk during Warfarin Therapy Is Associated with the Number of Variant Alleles of CYP2C9 and VKORC1 GenesCardiology, 2013
- MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysisTumor Biology, 2012
- ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancerMolecular Biology Reports, 2010
- ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancerEuropean Journal of Human Genetics, 2008
- Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancerCarcinogenesis, 2007
- ARLTS1 polymorphisms and basal cell carcinoma of the skinHereditary Cancer in Clinical Practice, 2007
- ARLTS1 variants and risk of colorectal cancerCancer Letters, 2006
- Familial Cancer Associated with a Polymorphism inARLTS1New England Journal of Medicine, 2005